Your session is about to expire
← Back to Search
Insulin icodec for Type 2 Diabetes (ONWARDS 1 Trial)
ONWARDS 1 Trial Summary
This trial compares a new weekly insulin to a daily insulin that is already on the market, in people with type 2 diabetes. It will look at how well the weekly insulin controls blood sugar compared to the daily insulin. The study will last for about 1 ½ years, with 37 clinic visits and 26 phone calls with the study doctor.
- Type 2 Diabetes
ONWARDS 1 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowONWARDS 1 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2020 Phase 2 trial • 247 Patients • NCT03751657ONWARDS 1 Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is Insulin icodec deadly if used incorrectly?
"Insulin icodec has been studied enough to support its efficacy and safety, and has thus been given a score of 3."
Is this trial commonly conducted in American hospitals?
"Currently, there are 55 sites worldwide where patients can enroll in this clinical trial. Kenosha, Fresno, Ventura and other cities have active locations where people can be enrolled. To limit travel, it is best to choose the location nearest to you."
Are there similar treatments to Insulin icodec that have been tested in the past?
"Insulin icodec was first trialled in 2005 by the Division of Paediatrics at Karolinska University Hospital. Since then, there have been 398 completed studies. There are 17 active studies currently underway, with a large concentration of these in Kenosha, Wisconsin."
How many people are you testing this medication on?
"Unfortunately, this study is no longer enrolling patients. The posting for this clinical trial was first published on November 25th, 2020 and was last updated on November 3rd, 2022. However, there are 1,453 other trials related to diabetes mellitus, type 2 currently enrolling patients and 17 trials for Insulin icodec that are still admitting participants."
What medical conditions are most often remedied by Insulin icodec?
"Insulin icodec is most commonly used as a form of diet control, but it also has benefits for patients with type 1 diabetes mellitus, type 2 diabetes mellitus, and hyperglycemia."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger